Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.260
+0.010 (0.80%)
At close: Jun 12, 2026, 4:00 PM EDT
1.270
+0.010 (0.79%)
After-hours: Jun 12, 2026, 4:04 PM EDT
Tempest Therapeutics Employees
Tempest Therapeutics had 4 employees as of December 31, 2025. The number of employees decreased by 20 or -83.33% compared to the previous year.
Employees
4
Change
-20
Growth
-83.33%
Revenue / Employee
n/a
Profits / Employee
-$10,774,500
Market Cap
18.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -20 | -83.33% |
| Jun 30, 2025 | 21 | - | - |
| Dec 31, 2024 | 24 | 7 | 41.18% |
| Dec 31, 2023 | 17 | -2 | -10.53% |
| Dec 31, 2022 | 19 | 2 | 11.76% |
| Dec 31, 2021 | 17 | 3 | 21.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Werewolf Therapeutics | 39 |
| Curis | 24 |
| Passage Bio | 24 |
| NewcelX | 12 |
| Cellectar Biosciences | 11 |
| AEON Biopharma | 8 |
| Exicure | 8 |
| Traws Pharma | 7 |
TPST News
- 5 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 9 days ago - Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - GlobeNewsWire
- 15 days ago - Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds - GlobeNewsWire
- 15 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Tempest Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Tempest Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Tempest Therapeutics Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Tempest Presents Clinical Update at ISCT 2026 Annual Meeting - GlobeNewsWire